BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36957981)

  • 1. Fecal Microbiota Transplantation as a Cancer Therapeutic.
    Stoff R; Wolf Y; Boursi B
    Cancer J; 2023 Mar-Apr 01; 29(2):102-108. PubMed ID: 36957981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological mechanisms of fecal microbiota transplantation in recurrent
    Soveral LF; Korczaguin GG; Schmidt PS; Nunes IS; Fernandes C; Zárate-Bladés CR
    World J Gastroenterol; 2022 Sep; 28(33):4762-4772. PubMed ID: 36156924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation: a review on current formulations in
    Rakotonirina A; Galperine T; Allémann E
    Expert Opin Biol Ther; 2022 Jul; 22(7):929-944. PubMed ID: 35763604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ecological framework to understand the efficacy of fecal microbiota transplantation.
    Xiao Y; Angulo MT; Lao S; Weiss ST; Liu YY
    Nat Commun; 2020 Jul; 11(1):3329. PubMed ID: 32620839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal microbiota transplantation for
    Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
    United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study.
    Osman M; Budree S; Kelly CR; Panchal P; Allegretti JR; Kassam Z;
    Gastroenterology; 2022 Jul; 163(1):319-322. PubMed ID: 35398345
    [No Abstract]   [Full Text] [Related]  

  • 9. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects].
    Batista R; Kapel N; Megerlin F; Chaumeil JC; Barbut F; Bourlioux P; Chast F
    Ann Pharm Fr; 2015 Sep; 73(5):323-31. PubMed ID: 25825054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
    Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
    Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of the gut microbiome following fecal microbiota transplantation.
    Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB
    mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent
    Wei S; Bahl MI; Baunwall SMD; Dahlerup JF; Hvas CL; Licht TR
    Gut Microbes; 2022; 14(1):2084306. PubMed ID: 36519447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of gut microbiota in tumorigenesis and treatment.
    Xu JY; Liu MT; Tao T; Zhu X; Fei FQ
    Biomed Pharmacother; 2021 Jun; 138():111444. PubMed ID: 33662679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota transplantation for recurrent clostridium difficile infection in children.
    Chen B; Avinashi V; Dobson S
    J Infect; 2017 Jun; 74 Suppl 1():S120-S127. PubMed ID: 28646951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report.
    Wei S; Jespersen ML; Baunwall SMD; Myers PN; Smith EM; Dahlerup JF; Rasmussen S; Nielsen HB; Licht TR; Bahl MI; Hvas CL
    Microbiome; 2022 Nov; 10(1):193. PubMed ID: 36352460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FMT: What's Next? A Narrative Review of Fecal Microbiota Transplantation in Clostridioides difficile Infection and Inflammatory Bowel Disease.
    Patwa SA; Ward C; Kelly CR
    R I Med J (2013); 2022 Nov; 105(9):20-24. PubMed ID: 36300959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.